RTSN

Retension Pharmaceuticals Inc.

There isn't enough reported data to score RTSN yet.

RTSN Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Unavailable

There isn't enough reported data to rate RTSN's fundamentals.

RTSN PE Valuation

RTSN has no meaningful PE right now: it lost money over the past year.

RTSN Forward outlook

There aren't enough analyst estimates for RTSN to show an outlook.

RTSN Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $12.25 on Nov 12.

There is not enough scenario data to assess RTSN's risk to reward.

RTSN Earnings Per Share

RTSN Quarterly Revenue

RTSN Free Cash Flow

RTSN Total Shares

RTSN Net Leverage

RTSN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

RTSN Weekly Momentum

As of the close on Nov 12, 2026: $12.25.

RTSN PE vs Healthcare Sector

RTSN has no meaningful PE right now: it lost money over the past year.

RTSN Weekly Moving Averages

As of the close on Nov 12, 2026: $12.25.

RTSN Yearly ROI

YearStart priceEnd priceROI
2026 YTD$10.5$12.3+16%

It's up 16% so far in 2026.

Give your agent the market.

Get API key